Johnson & Johnson is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Johnson & Johnson researches and produces pharmaceuticals, develops medical devices, and produces consumer products both directly and through its subsidiaries. Its pharmaceutical arm, Janssen Pharmaceuticals, works to research diseases. J&J also sells well-known consumer goods including Band-Aid, Tylenol, Johnson’s Baby, Clean & Clear, and Acuvue products.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Healthcare is a central component of our measure of Humankind Value, as a large contribution to modern life expectancies has come from the last 150 years of medical innovation. Johnson & Johnson is responsible for positive Humankind Value. Notable sources of positive value are Healthcare R&D ($397.6 B), Pharmaceuticals ($165.4 B), and Medical Devices ($124.9 B). Out of every company we have analyzed, Johnson & Johnson is in the top ten for Healthcare R&D, Pharmaceuticals, and Medical Devices. The value associated with these categories alone includes an estimated 14,272,922.5 additional years lived by people worldwide. This firm could increase its Humankind Value by addressing Greenhouse Gases (-$5.9 B) and Opioid Abuse (-$2.1 B). Healthcare R&D, Pharmaceuticals, Medical Devices, and Greenhouse Gases are attached to this company as a result of its direct business activities. Opioid Abuse is mostly or entirely a result of supply-chain relationships.